Literature DB >> 20635168

Multidrug resistance strength of the novel multidrug resistance gene HA117: compared with MRP1.

Lihua Zhao1, Yanhui Sun, Xiaoqing Li, Xianqing Jin, Youhua Xu, Zhenhua Guo, Rui Liang, Xionghui Ding, Tingfu Chen, Siqi Wang.   

Abstract

The novel gene HA117 is a multidrug resistance (MDR) gene in all-trans retinoic acid resistance HL-60 cells. The transduction of adenovirus vectors encoding HA117 conferred breast cancer cell line 4T1 MDR not only to MRP1 substrate drugs but also to MRP1 non-substrate drugs and the MDR strength of HA117 was similar to that of multidrug resistance-associated protein-1 (MRP1) for MRP1 substrate, but HA117 had no daunorubicin-excretion function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635168     DOI: 10.1007/s12032-010-9624-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

Review 1.  ABC transporters: physiology, structure and mechanism--an overview.

Authors:  C F Higgins
Journal:  Res Microbiol       Date:  2001 Apr-May       Impact factor: 3.992

2.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.

Authors:  Jinyong Luo; Zhong-Liang Deng; Xiaoji Luo; Ni Tang; Wen-Xin Song; Jin Chen; Katie A Sharff; Hue H Luu; Rex C Haydon; Kenneth W Kinzler; Bert Vogelstein; Tong-Chuan He
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor.

Authors:  Naoyuki Komura; Yoko Ikeda; Natsuko Masuda; Yoji Umezawa; Keisuke Ito; Masahiro Kizaki; Kazuo Umezawa
Journal:  Leuk Res       Date:  2006-09-11       Impact factor: 3.156

Review 4.  Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients.

Authors:  Frauke Bellos; Ulrich Mahlknecht
Journal:  Onkologie       Date:  2008-10-23

Review 5.  Multidrug resistance through the spectacle of P-glycoprotein.

Authors:  Katalin Goda; Zsolt Bacsó; Gábor Szabó
Journal:  Curr Cancer Drug Targets       Date:  2009-05       Impact factor: 3.428

6.  MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.

Authors:  Michael Heuser; Bob Argiropoulos; Florian Kuchenbauer; Eric Yung; Jessica Piper; Stephen Fung; Richard F Schlenk; Konstanze Dohner; Tanja Hinrichsen; Cornelia Rudolph; Axel Schambach; Christopher Baum; Brigitte Schlegelberger; Hartmut Dohner; Arnold Ganser; R Keith Humphries
Journal:  Blood       Date:  2007-05-09       Impact factor: 22.113

7.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Authors:  R P Warrell; S R Frankel; W H Miller; D A Scheinberg; L M Itri; W N Hittelman; R Vyas; M Andreeff; A Tafuri; A Jakubowski
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

Review 8.  Retinoic acid resistance in acute promyelocytic leukemia.

Authors:  R E Gallagher
Journal:  Leukemia       Date:  2002-10       Impact factor: 11.528

9.  Adenoviral mediated transduction of adenoid cystic carcinoma by human TRAIL gene driven with hTERT tumor specific promoter induces apoptosis.

Authors:  Guangxiang Zang; Leiying Miao; Yabing Mu; Chunyan Qiao; Jinzhong Liu; Xiaoliang Ke; Changyu Zheng; Hongchen Sun
Journal:  Cancer Biol Ther       Date:  2009-05       Impact factor: 4.742

10.  HA117 gene increased the multidrug resistance of K562 cells in vitro: an investigation to the function of a novel gene related to drug resistance.

Authors:  Yuxia Guo; Gaihuan Zheng; Xianqing Jin; Youhua Xu; Qing Luo; Xiaomei Liu; Zhenzhen Zhao; Yong Chen
Journal:  J Exp Clin Cancer Res       Date:  2009-05-12
View more
  2 in total

1.  Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.

Authors:  Wen Tan; Hu Mei; Li Chao; Tengfei Liu; Xianchao Pan; Mao Shu; Li Yang
Journal:  J Comput Aided Mol Des       Date:  2013-12-10       Impact factor: 3.686

2.  Kinetics of MDR transport in tumor-initiating cells.

Authors:  Vasilij Koshkin; Burton B Yang; Sergey N Krylov
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.